These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 5924281

  • 1. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE, Rosenfeld PS, Bokat MA.
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract] [Full Text] [Related]

  • 2. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE, Westbie DK, Daly R, Bower RH.
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [Abstract] [Full Text] [Related]

  • 3. Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.
    Miura K, Sasaki C, Katsushima I, Ohtomo T, Sato S, Demura H, Torikai T, Sasano N.
    J Clin Endocrinol Metab; 1967 May; 27(5):631-7. PubMed ID: 4290580
    [No Abstract] [Full Text] [Related]

  • 4. Overnight suppression test with dexamethasone in Cushing's syndrome.
    Sawin CT, Bray GA, Idelson BA.
    J Clin Endocrinol Metab; 1968 Mar; 28(3):422-4. PubMed ID: 4868264
    [No Abstract] [Full Text] [Related]

  • 5. [Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
    Medizinische Poliklinik der Universität Würzburg.
    MMW Munch Med Wochenschr; 1975 May 30; 117(22):955-6. PubMed ID: 168485
    [No Abstract] [Full Text] [Related]

  • 6. [A case of Cushing's disease with paradoxical response to dexamethasone].
    Kubo M, Nakagawa K, Akikawa K, Matsubara M, Ishizuka T, Nakagawa S.
    Nihon Naika Gakkai Zasshi; 1986 Jan 30; 75(1):75-82. PubMed ID: 3009668
    [No Abstract] [Full Text] [Related]

  • 7. Intermittent Cushing's syndrome with anomalous response to dexamethasone.
    Brooks RV, Jeffcoate SL, London DR, Prunty FT, Smith PM.
    J Endocrinol; 1966 Sep 30; 36(1):53-61. PubMed ID: 4288409
    [No Abstract] [Full Text] [Related]

  • 8. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW, Beardwell CG.
    Q J Med; 1973 Jan 30; 42(165):175-204. PubMed ID: 4688791
    [No Abstract] [Full Text] [Related]

  • 9. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O, Jørgensen H, Frey H, Norman N.
    Tidsskr Nor Laegeforen; 1989 Sep 20; 109(26):2678-82. PubMed ID: 2554527
    [Abstract] [Full Text] [Related]

  • 10. Reliability and significance of the dexamethasone suppression test in Cushing's disease.
    N Engl J Med; 1967 Aug 24; 277(8):431. PubMed ID: 4378315
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
    Batista DL, Riar J, Keil M, Stratakis CA.
    Pediatrics; 2007 Sep 24; 120(3):e575-86. PubMed ID: 17698579
    [Abstract] [Full Text] [Related]

  • 12. Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    Carey RM.
    N Engl J Med; 1980 Jan 31; 302(5):275-9. PubMed ID: 6243171
    [No Abstract] [Full Text] [Related]

  • 13. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
    Caduff F, Staub JJ, Nordmann A, Radü EW, Landolt H.
    Schweiz Med Wochenschr; 1991 Jan 09; 121(1-2):10-20. PubMed ID: 1990418
    [Abstract] [Full Text] [Related]

  • 14. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 09; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 15. Cushing's syndrome with fluctuation due to adrenal adenoma.
    Green JR, van't Hoff W.
    J Clin Endocrinol Metab; 1975 Aug 09; 41(2):235-40. PubMed ID: 1159041
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
    Hermus AR, Pieters GF, Smals AG, Pesman GJ, Lamberts SW, Benraad TJ, van Haelst UJ, Kloppenborg PW.
    N Engl J Med; 1988 Apr 14; 318(15):966-70. PubMed ID: 2832758
    [No Abstract] [Full Text] [Related]

  • 19. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC, Sheeler LR, Engeland WC, Aron DC.
    J Clin Endocrinol Metab; 1993 Jan 14; 76(1):189-91. PubMed ID: 8380604
    [Abstract] [Full Text] [Related]

  • 20. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW, Raff H, Aron DC.
    J Clin Endocrinol Metab; 2004 Mar 14; 89(3):1222-6. PubMed ID: 15001614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.